CYPH
Cypherpunk Technologies Inc.
There isn't enough reported data to score CYPH yet.
CYPH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
CYPH's revenue is currently stable, but its profitability is under pressure. There isn't enough data to rate its cash flow and balance sheet.
CYPH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 3.5x | $1.95 | — |
| Cheap | 3.7x | $2.09 | +7.4% |
| Fair | 5.4x | $3.00 | +54% |
| Forward | 5.6x | $1.95 | — |
| Expensive | 13x | $7.33 | +276% |
Historical ranges are pointers, not guarantees.
CYPH's PE is 3.5x, but its earnings don't support one, so it isn't a reliable read right now.
CYPH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Returning to profit | |
| Strong growth | |
| -- | |
| Limited | |
| High |
Analysts expect CYPH to return to profit, with revenue growing.
CYPH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.35 | -37% |
| Q2 2026 | $0.56 | +$2.11 |
| Q1 2026 | -$0.02 | +$1.65 |
| Q4 2025 | $0.07 | +$1.88 |
| Q3 2023 | -$5.72 | -$1.12 |
| Q2 2023 | -$6.51 | -$1.81 |
| Q1 2023 | -$7.10 | -$2.70 |
| Q4 2022 | -$4.80 | -$0.10 |
CYPH has returned to profit: it earned $0.56 per share over the past year, after losing money the year before.
CYPH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2021 | $375K | 0% |
| Q3 2021 | $375K | 0% |
| Q2 2021 | $375K | 0% |
| Q1 2021 | $375K | 0% |
CYPH's revenue has held roughly level: $375,000 last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2021 | -2797% | -889 points |
| Q3 2021 | -3237% | -1235 points |
| Q2 2021 | -2567% | -568 points |
| Q1 2021 | -2446% | -744 points |
| Q4 2020 | -1908% | N/A |
| Q3 2020 | -2002% | N/A |
| Q2 2020 | -1999% | N/A |
| Q1 2020 | -1702% | N/A |
CYPH's operating margin was −2797% last quarter, down 889 points from the same quarter a year ago.
CYPH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$2.7M | +$11.8M |
| Q1 2026 | -$3.4M | +$11.1M |
| Q4 2025 | -$6.6M | +$8.9M |
| Q3 2025 | -$8.3M | +$7.3M |
| Q2 2025 | -$14.5M | -$815K |
| Q1 2025 | -$14.5M | +$1M |
| Q4 2024 | -$15.5M | -$5.1M |
| Q3 2024 | -$15.6M | -$5.1M |
CYPH has burned cash in almost every quarter: −$21M over the past year, against −$60M the year before.
CYPH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +29% | +49.2M shares |
| 1 year | +427% | +176M shares |
| 3 years | +1819% | +206M shares |
| 5 years | +2748% | +210M shares |
CYPH has 217M diluted shares, up 427% from a year ago.
CYPH Net Leverage
CYPH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 49.7 | Neutral |
| Stochastic | 55.7 | Neutral |
CYPH's weekly RSI is 50 (neutral) and its Stochastic is 56 (neutral).
CYPH PE vs Healthcare Sector
| Metric | CYPH | Sector median | Relative |
|---|---|---|---|
| PE | 3.5x | 26x | 87% below |
| PE % | 14 | 29 | 15 pts below |
CYPH is trading at 3.5x earnings, a 87% discount to the Healthcare sector's median of 26x, though its earnings don't support one.
CYPH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.91 | 33% below |
| 20 week MA | $1.97 | 1% below |
| 50 week MA | $1.32 | 48% above |
| 100 week MA | $1.06 | 84% above |
| 200 week MA | $2.12 | 8% below |
CYPH's trend is mixed: it's above two of its five weekly moving averages, and 8% below its 200-week average.
CYPH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $11.0 | $22.2 | +102% |
| 2021 | $22.2 | $29.5 | +33% |
| 2022 | $29.5 | $4.70 | -84% |
| 2023 | $4.70 | $4.14 | -12% |
| 2024 | $4.14 | $2.95 | -29% |
| 2025 | $2.95 | $1.20 | -59% |
| 2026 YTD | $1.20 | $1.95 | +63% |
CYPH has finished four years in a row lower, and it's up 63% so far in 2026.